Friday, September 14, 2012

• Top Biotechnology Stock Picks from Oppenheimer & Company Research AnalystWall Street Transcript (Fri, Sep 14)
• Vivus Is Cheaper Than Arenaat Seeking Alpha (Fri, Sep 14)
• [video] The Next Big Thing in Biotech: Obesity Drugsat TheStreet (Fri, Sep 14)

Wednesday, September 12, 2012

• Why is Orbimed Backing Out of Amarin?at Motley Fool (Wed, Sep 12)
• Is It Time To Buy Into The Anti-Obesity Drug Hype?at Motley Fool (Wed, Sep 12)
• VIVUS INC Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and ExhibitsEDGAR Online (Wed, Sep 12)
• Will Physicians Prescribe Vivus' Qysmia?at Seeking Alpha (Wed, Sep 12)
• 3 Things to Watch With Arena Pharmaceuticalsat Motley Fool (Wed, Sep 12)

Sunday, September 9, 2012

• INVESTING INSIGHTS: Here’s How Weight-Loss Treatments are Boosting These Stocksat Wall St. Cheat Sheet (Sun, Sep 9)
• Credit Suisse Sets A New Low Standard For Poor Analysis In Their Coverage Of Arena Pharmaceuticalsat Motley Fool (Sun, Sep 9)

Saturday, September 8, 2012

• Another Weight Loss Drug Gets Props from Wall Streetat Wall St. Cheat Sheet (Sat, Sep 8)
• Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocksat Seeking Alpha (Sat, Sep 8)

Friday, September 7, 2012

• Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Marketat Seeking Alpha (Fri, Sep 7)
• 3 Winners That Trounced Market "Eur-phoria"at Motley Fool (Fri, Sep 7)
• Arena Pharmaceuticals Price Target Sets Low Barat Seeking Alpha (Fri, Sep 7)

Thursday, September 6, 2012

• Big Demand for (Free) Obesity Drugsat Motley Fool (Thu, Sep 6)
• Sector Snap: Weight loss drugmakers mixedAP (Thu, Sep 6)
• Here's What This $39 Billion Hedge Fund Giant Has Been Buyingat Motley Fool (Thu, Sep 6)

Wednesday, September 5, 2012

• Obesity Pandemic Addressed By Collaboration Between American, Swiss, Japanese Companiesat Motley Fool (Wed, Sep 5)
• Buy or Sell? Wednesday's Winners: GWRE, OREXat Investopedia (Wed, Sep 5)

Saturday, September 1, 2012

• Are the Shorts Wrong About: VIVUS?at Motley Fool (Sat, Sep 1)
• Questcor Pharmaceuticals Has Significant Upside Potentialat Seeking Alpha (Sat, Sep 1)

Thursday, August 30, 2012

• 3 Things to Watch With VIVUSat Motley Fool (Thu, Aug 30)
• Arena And Vivus Set To Dominate The Obesity Drug Marketat Seeking Alpha (Thu, Aug 30)
• Perspective On Value At Vivusat Seeking Alpha (Thu, Aug 30)

Add VVUS News to My Yahoo!